XML 31 R15.htm IDEA: XBRL DOCUMENT v3.6.0.2
Symphony Dynamo, Inc.
12 Months Ended
Dec. 31, 2016
Business Combinations [Abstract]  
Symphony Dynamo, Inc.

8.

Symphony Dynamo, Inc.

In conjunction with a financing arrangement with Symphony Dynamo, Inc. and Symphony Dynamo Holdings LLC (“Holdings”) in November 2009, we agreed to make contingent cash payments to Holdings equal to 50% of the first $50 million from any upfront, pre-commercialization milestone or similar payments received by us from any agreement with any third party with respect to the development and/or commercialization of cancer and hepatitis C therapies originally licensed to Symphony Dynamo, Inc., including SD-101. We have made no payments and have not recorded a liability as of December 31, 2016.